Nfkbiz is an inhibitor of nuclear factor κB (IκB) protein localized to the nucleus. We previously found that Nfkbiz gene-disrupted mice showed atopic dermatitis-like lesion, implying the important role of Nfkbiz in skin homeostasis. The purpose of this study was to examine the effect of interferon (IFN)-γ on Nfkbiz expression in keratinocytes. IFN-γ induced Nfkbiz expression at a comparable level to IL-1. Promoter analysis revealed that interferon-stimulated response element (ISRE) located in the Nfkbiz promoter region is important for responding to the stimulation. Interestingly, IFN-γ and IL-1 displayed synergism in terms of inducing Nfkbiz expression. By using selective inhibitors, we found that Janus activated kinase (JAK) 1 and nuclear factor (NF)-κB are important for Nfkbiz expression after IFN-γ stimulation and for synergism between IFN-γ and IL-1. These findings indicate a possible important role of Nfkbiz in modulating the progression of inflammatory diseases in which IFN-γ and IL-1 are abundant.
Nfkbiz is an inhibitor of nuclear factor κB (IκB) protein localized to the nucleus that is also termed 'molecule possessing ankyrin-repeats induced by lipopolysaccharide (MAIL)', 'interleukin-1-inducible nuclear ankyrin repeat protein (INAP)', or IκBζ (5, 8, 20) . Nfkbiz acts as a transcriptional regulator of various genes on inflammatory stimuli such as LPS and IL-1 (19) . We previously found that Nfkbiz gene-disrupted mice showed atopic dermatitis-like lesion (16) and that Nfkbiz was constitutively expressed in epidermal keratinocytes (13) . This constitutive expression was shown to be mediated by the activity of nuclear factor (NF)-κB (13) .
Interferon (IFN)-γ is a well-characterized, potent inflammatory stimulus in a variety of biological systems (2) . It exerts its cellular effects by interacting with its cell surface receptor, IFN-γR, which is composed of two subunits. The binding of IFN-γ to its receptor induces receptor oligomerization and activation of the receptor-associated kinases called Janus activated kinase (JAK) 1 and JAK2 by transphosphorylation (15) . Activated JAKs phosphorylate tyrosine residues within the cytoplasmic domains of the receptor subunits, which act as docking sites for STAT1 (2) . Phosphorylation of STAT1 mediates dimerization, which enables STAT1 dimers to translocate to the nucleus and bind to IFN-γ-activated sequence (GAS) or interferon-stimulated response element (ISRE) located within the promoters of IFN-γ-inducible genes (18) . Keratinocytes express IFN-γ receptor and IFN-γ induces cytokine and chemokine synthesis in these cells (4, 10) . IFN-γ is also known to promote exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis, implying its important role in skin disor-analyzed for the expression of Nfkbiz using an ABI PRISM 7700 with previously described primers and probes (13) . The amount of target gene expression was calculated from the standard curves and was normalized using the expression of 18S ribosomal RNA as an internal control.
Luciferase assay. PAM212 cells were plated at 50% confluence in 12-well plates. After overnight cultivation, the cells were transfected with plasmids (0.4 mg/ well) using FuGENE transfection reagent (Roche Diagnostics, Indianapolis, IN, USA). The pRL-tk vector was used as an internal control (Promega). Two days after transfection, IL-1 (20 ng/mL) and IFN-γ (20 ng/mL) were added. After an additional one hour of incubation, the cells were washed once in PBS and lysed in Passive Lysis Buffer (Promega). Luciferase activity was measured using the DualLuciferase reporter assay system (Promega) as previously described (6) .
RESULTS

Expression analysis of Nfkbiz after stimulation with IFN-γ in primary keratinocytes and keratinocyte cell line PAM212
To determine the effect of IFN-γ on Nfkbiz expression in keratinocytes, we carried out qRT-PCR. As a positive control, we used IL-1 because this cytokine is known to induce Nfkbiz expression strongly in keratinocytes and macrophages. In primary keratinocytes, IFN-γ increased Nfkbiz expression by 7.7-fold (Fig. 1a) . The magnitude of Nfkbiz expression by IFN-γ was comparable to that by IL-1 (Fig. 1a) . IFN-γ also increased Nfkbiz expression by 1.8-fold in the keratinocyte cell line PAM212 (Fig. 1b) . Interestingly, co-stimulation with IFN-γ plus IL-1 synergistically enhanced Nfkbiz expression in both primary keratinocytes and PAM212 (Fig. 1 ).
Promoter analysis of Nfkbiz
To determine whether ISREs in the Nfkbiz promoter are important for Nfkbiz expression, we performed truncation analysis of this promoter. We used two fragments. One was a −723 to +18-bp Nfkbiz promoter fragment that contains three ISREs and the other was a −357 to +18-bp Nfkbiz promoter fragment. We transfected these constructs into PAM212 cells and measured luciferase activity in the presence or absence of IFN-γ plus IL-1. When the ISRE containing region (−723 to −358) was deleted, promoter responsiveness significantly decreased (Fig. 2) . The promoter activities of unstimulated controls were ders (14) . Recently, it was reported that several ISREs are located at the Nfkbiz promoter region, although there is no evidence that IFN-γ is involved in Nfkbiz expression (17) . In the present study, we examined the effect of IFN-γ on Nfkbiz expression in epidermal keratinocytes and showed that IFN-γ is a strong inducer of Nfkbiz in keratinocytes.
MATERIALS AND METHODS
Animals. Wild-type pregnant C57BL/6 mice were purchased from SLC Japan Inc. (Hamamatsu, Japan). The experimental procedure and care of animals were in accordance with the National University Corporation Hokkaido University Regulations on Animal Experimentation.
Cell culture. Primary keratinocytes were isolated from neonatal mice as previously reported (13) . In brief, neonatal mice were sacrificed within 3 days of birth, and the skin was excised and sterilized using 70% ethanol. After overnight dispase treatment to separate the epidermis and dermis, the epidermis was trypsinized for 10 min at 37°C to disaggregate the keratinocytes. The trypsin was neutralized with PBS containing 5% chelex-treated fetal calf serum (FCS). Then, cells were washed with serum-free PBS twice and suspended in serum-free keratinocyte growth medium (KGM2 Bullet kit; Cambrex, Walkersville, MD, USA) containing 20 μM CaCl 2 , 1 × human keratinocyte growth supplement, 100 U/mL penicillin, and 100 μg/mL streptomycin. The mouse keratinocyte cell line PAM212 was a kind gift from Dr. Hajime Nakano (Hirosaki University). The cells were maintained at 37°C in 5% CO 2 in Eagle's minimum essential medium supplemented with 10% heat-inactivated FCS, 100 U/mL penicillin, and 100 μg/mL streptomycin.
Reagents. IL-1β was obtained from Wako (Osaka, Japan). Bay11-7082 was obtained from Biomol Research Laboratories (Plymouth Meeting, PA, USA). AG490 and pan-JAK inhibitor were obtained from Calbiochem (San Diego, CA, USA).
Quantitative reverse transcription-polymerase chain reaction (qRT-PCR).
Total RNA was prepared from cells using TRIzol reagent (Invitrogen Corp., Carlsbad, CA, USA). After RNA extraction, reverse transcription reaction was carried out using SuperScript II (Invitrogen) according to the manufacturer's instructions. Complementary DNA was quantitatively combined stimulation, pan-JAK inhibitor and Bay11-7082 showed significant effects on Nfkbiz expression in PAM212 cells treated with IL-1 alone or IFN-γ alone (Fig. 3c) .
DISCUSSION
Nfkbiz was originally identified in macrophages (8) . Interestingly, Nfkbiz gene-disrupted mice showed atopic dermatitis-like lesion, indicating that Nfkbiz has an important role in the skin (16) . However, the role of Nfkbiz in keratinocytes is largely unknown. We previously reported that Nfkbiz is constitutively expressed in keratinocytes and its expression is mediated by NF-κB (13) . In this study we examined the role of IFN-γ in regulating Nfkbiz expression in keratinocytes. IFN-γ induced Nfkbiz expression at a comparable level to IL-1, a strong inducer of Nfkbiz in keratinocytes, indicating that IFN-γ plays an important role in regulating Nfkbiz expression in keratinocytes. Thus, we identified Nfkbiz as one of the interferon-stimulated genes (ISGs). Our finding suggests that there may be a positive-feedback mechanism between IFN-γ and Nfkbiz because it is known that Nfkbiz enhances IFN-γ expression in response to certain kinds of inflammatory cytokine (7). In the following experiments, we examined the role of ISREs of the Nfkbiz promoter in Nfkbiz expression in keratinocytes. In general, ISRE exists in ISGs with the consensus sequence of AGTTCNNTTCC (where N is any nucleotide) (18) . The IFN-γ/IL1-stimulated activation of Nfkbiz promoter was significantly lowered by the deletion of ISREs, indicating that ISREs in the Nfkbiz promoter are functional and important for responding to stimulation. IFN-γ synergistically induced Nfkbiz expression in concurrent stimulation with IL-1. It is known that IFN-γ plus IL-1 synergistically induce inflammatory cytokine expression in certain types of cell (3, 21) . Both NF-κB binding sites and ISREs in the promoter region of target genes are important for this synergism (3). Although the biological significance of this synergism is still to be determined, it is possible that stimulus-induced Nfkbiz suppresses the progression of inflammatory conditions such as atopic dermatitis in a different way from constitutively expressed Nfkbiz. The JAK/STAT pathway plays a central role downstream of IFN signaling (1) . JAK associates with the IFN receptor, which transmits the signal to STAT family molecules. There are four kinds of JAK family molecule, JAK1, JAK2, JAK3, and Tyk2 (1). Among them, JAK1 and JAK2 are important for the also decreased by the deletion.
Effects of selective inhibitors on Nfkbiz expression in keratinocytes
We used selective inhibitors to investigate which signaling pathway is involved in Nfkbiz expression after stimulation with IFN-γ plus IL-1 in keratinocytes. We used three compounds; AG490 as a JAK2 inhibitor, pan-JAK inhibitor as a broad inhibitor of JAK 1 to 3, and Bay11-7082 as an inhibitor of NF-κB. In primary keratinocytes, pan-JAK inhibitor and Bay11-7082 significantly reduced Nfkbiz expression, although AG490 did not show any effect after stimulation (Fig. 3a) . Similar effects were observed when PAM212 cells were analyzed (Fig. 3b) . Next, to analyze the signaling mechanism in detail, we stimulated PAM212 cells with a single stimulus, IL-1 or IFN-γ, after treatment with inhibitors. Similar to Bay11-7082 as an NF-κB inhibitor to examine the role of NF-κB in Nfkbiz expression after IFN-γ stimulation because NF-κB is involved in the constitutive expression of Nfkbiz and is currently the only known IFN-γ signaling pathway (18) . We used two kinds of inhibitor of JAKs. One was a specific JAK2 inhibitor, AG490, and the other was a broad inhibitor of the JAK family, pan-JAK inhibitor. We also used transcriptional factor of Nfkbiz in keratinocytes (13) . Pan-JAK inhibitor and Bay11-7082 blocked the effect of stimulation. These results suggest that JAK1 but not JAK2 is critical for Nfkbiz expression in the JAK/STAT pathway and that NF-κB is an important transcriptional factor to respond to an inflammatory stimulus such as IFN-γ as well as the constitutive expression of Nfkbiz in the resting keratinocytes. Our findings that both JAK/STAT and NF-κB pathways are important for the synergism are consistent with a previous report on CXCL10 (3) . Although STAT3 is known to play a very important role in inducing Nfkbiz expression in immune cells among the STAT family (9, 11, 12) , the central STAT molecule acting downstream of IFN-γ signaling is STAT1 or STAT2 rather than STAT3 (1, 15) . The precise role of STATs in the regulation of Nfkbiz expression seems to be complicated and further analysis is needed.
In conclusion, we showed that IFN-γ induces Nfkbiz expression in epidermal keratinocytes. The effect of IFN-γ on Nfkbiz induction is synergistically enhanced by concurrent stimulation with IL-1. ISREs in the Nfkbiz promoter region are important for the response to IFN-γ stimulation. JAK1, but not JAK2, and the NF-κB pathway are important for Nfkbiz expression in keratinocytes.
